[Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)].
作者信息
Hirano M, Morishita Y, Ino T, Matsui T, Shimizu S, Shigemura H, Nakamura K, Ono Y, Saito M
出版信息
Rinsho Ketsueki. 1981 Mar;22(3):299-305.
PMID:6944508
Abstract
摘要
相似文献
1
[Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)].N4-山嵛酰基-β-D-阿拉伯呋喃糖胞苷、阿克拉霉素A、6-巯基嘌呤和泼尼松龙联合治疗急性非淋巴细胞白血病；一项初步研究（作者译）
Rinsho Ketsueki. 1981 Mar;22(3):299-305.
2
3
4
[Adriamycin-aclacinomycin therapy (AA therapy) for acute leukemia unresponsive to BH-AC-DMP therapy].[阿霉素-阿克拉霉素疗法（AA疗法）用于对BH-AC-DMP疗法无反应的急性白血病]
Gan To Kagaku Ryoho. 1983 Jun;10(6):1473-9.
5
6
7
8
[Revaluation of the two step DCMP chemotherapy for acute leukemias (author's transl)].
Rinsho Ketsueki. 1979 Oct;20(10):1340-6.
9
Behenoyl cytosine arabinoside, aclacinomycin A, 6-mercaptopurine, and prednisolone combination therapy for acute non-lymphocytic leukaemia in adults.
Eur J Haematol. 1989 Jul;43(1):1-6. doi: 10.1111/j.1600-0609.1989.tb01243.x.
10
[Treatment of refractory acute lymphocytic leukemia in childhood with BH-AC, ACM, 6-MP, and prednisolone].[采用BH-AC、ACM、6-巯基嘌呤和泼尼松龙治疗儿童难治性急性淋巴细胞白血病]
Rinsho Ketsueki. 1984 May;25(5):613-8.
Zotero 插件